SecSonar.com

Exicure, Inc. (XCUR)

Exicure, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Exicure, Inc. (XCUR) is a Biotechnology company based in US with a market capitalization of $20.1M. Free cash flow was negative at -$8.6M. This page tracks XCUR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 7 employees · IPO May 22, 2018

Valuation

Valuation & price

$2.81 · as of May 25, 2026 · -68.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.86$5.38$1.91Jul 25Dec 25Jul 26Jul 7, 25$6.47Jul 9, 25$7.11Jul 11, 25$7.27Jul 15, 25$6.85Jul 17, 25$7.71Jul 21, 25$8.86Jul 23, 25$8.38Jul 25, 25$7.85Jul 29, 25$6.63Jul 31, 25$7.13Aug 4, 25$7.60Aug 6, 25$7.69Aug 11, 25$7.58Aug 13, 25$7.15Aug 15, 25$6.65Aug 19, 25$6.40Aug 21, 25$6.20Aug 25, 25$5.92Aug 27, 25$5.71Aug 29, 25$5.61Sep 3, 25$5.13Sep 5, 25$4.75Sep 9, 25$4.15Sep 11, 25$3.60Sep 16, 25$4.00Sep 18, 25$3.88Sep 22, 25$3.72Sep 24, 25$4.25Sep 26, 25$3.81Sep 30, 25$4.09Oct 2, 25$4.18Oct 6, 25$4.27Oct 8, 25$5.32Oct 10, 25$4.95Oct 14, 25$5.10Oct 16, 25$4.90Oct 21, 25$4.65Oct 23, 25$4.74Oct 27, 25$4.68Oct 29, 25$4.46Oct 31, 25$4.40Nov 4, 25$4.23Nov 6, 25$4.25Nov 10, 25$3.87Nov 12, 25$3.60Nov 14, 25$3.71Nov 18, 25$3.73Nov 20, 25$4.18Nov 25, 25$3.82Nov 28, 25$4.18Dec 2, 25$5.54Dec 4, 25$6.74Dec 8, 25$5.33Dec 10, 25$5.32Dec 12, 25$6.35Dec 16, 25$6.06Dec 18, 25$6.09Dec 22, 25$5.88Dec 24, 25$6.00Dec 29, 25$5.47Jan 2, 26$5.58Jan 6, 26$5.89Jan 8, 26$5.88Jan 12, 26$5.84Jan 14, 26$6.00Jan 16, 26$6.22Jan 21, 26$6.28Jan 23, 26$6.16Jan 27, 26$4.45Jan 29, 26$4.26Feb 2, 26$4.20Feb 4, 26$4.08Feb 9, 26$4.39Feb 11, 26$4.25Feb 13, 26$4.08Feb 18, 26$3.66Feb 20, 26$3.58Feb 24, 26$3.59Feb 26, 26$3.71Mar 2, 26$3.62Mar 4, 26$3.57Mar 6, 26$4.15Mar 10, 26$4.12Mar 12, 26$3.94Mar 17, 26$4.54Mar 19, 26$4.75Mar 23, 26$4.39Mar 25, 26$4.61Mar 27, 26$4.42Mar 31, 26$4.25Apr 2, 26$4.19Apr 7, 26$3.84Apr 9, 26$4.10Apr 13, 26$3.85Apr 15, 26$3.96Apr 17, 26$3.79Apr 22, 26$3.64Apr 24, 26$3.47Apr 28, 26$3.47Apr 30, 26$3.36May 4, 26$3.25May 6, 26$3.39May 8, 26$3.37May 12, 26$3.24May 14, 26$3.18May 18, 26$3.06May 20, 26$2.99May 22, 26$2.81May 28, 26$2.97Jun 1, 26$3.33Jun 3, 26$3.16Jun 5, 26$2.92Jun 9, 26$2.85Jun 11, 26$2.82Jun 15, 26$2.79Jun 17, 26$2.15Jun 22, 26$2.74Jun 24, 26$2.69Jun 26, 26$2.40Jul 2, 26$1.91
$1.9152-week range$8.86
Loading valuation history…

Fundamentals

Key fundamentals

$20.1M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$8.6M

Free cash flow (USD)

-$3.6M

Net debt

Net cash position

3.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.0MFY 2017$9.7MFY 2018$118.0KFY 2019$1.3MFY 2020$16.6MFY 2021$-483.0KFY 2022$28.8MFY 2023$0.00FY 2024$500.0KFY 2025$0.00
$1M$0

Free cash flow by year

2016 → 2025

FY 2016$-5.4MFY 2017$-20.7MFY 2018$-19.6MFY 2019$235.0KFY 2020$-42.4MFY 2021$-35.8MFY 2022$-35.7MFY 2023$-10.4MFY 2024$-2.9MFY 2025$-8.6M
-$5.4M-$8.6M

Gross margin by year

2021 → 2024

FY 2021100.0%FY 202293.6%FY 2024100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 29, 2026 (EPS $-0.29)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard ChangesJun 30, 2026Filing
  • 8-K eventNASDAQ Compliance NotificationJun 1, 2026Filing
  • Quarterly report10-Q FiledMay 29, 2026Filing
  • 8-K eventDirector AppointmentApr 10, 2026Filing
  • 8-K eventSettlement AgreementApr 2, 2026Filing

Questions

Frequently asked questions

What is Exicure, Inc.'s market cap?

Exicure, Inc. (XCUR) has a market capitalization of $20.1M.

What is XCUR's P/E ratio?

A meaningful P/E ratio is not available for XCUR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is XCUR's price-to-book (P/B) ratio?

XCUR trades at 5.13 times book value per share.

When did Exicure, Inc. last report earnings?

XCUR last reported earnings on May 29, 2026; the next date is not yet scheduled.

Are insiders buying XCUR stock?

SEC Form 4 filings show no open-market insider buys at Exicure, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SER

Serina Therapeutics, Inc.

$20M

ABVC

ABVC BioPharma, Inc.

$20.3M

PLUR

Pluri Inc.

$20.7M

KZIA

Kazia Therapeutics Limited

$20.8M

VTGN

VistaGen Therapeutics, Inc.

$20.9M

DARE

Daré Bioscience, Inc.

$21.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.